Friday, January 2, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

HP Shares Face Mounting Pressure as Morgan Stanley Sounds Warning

Dieter Jaworski by Dieter Jaworski
November 17, 2025
in Analysis, Tech & Software
0
HP Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

A significant downgrade from Morgan Stanley has cast a shadow over HP’s stock prospects, with the firm reducing its rating to “Underweight” and slashing its price target from $26 to $24. This bearish assessment comes despite some positive operational performance, creating a complex narrative for the technology company.

Diverging Business Units Create Challenges

The core of Morgan Stanley’s concern lies in HP’s printer division, which continues to underperform while the company’s PC segment shows resilience. Market experts highlight that the printer business, a traditional cornerstone for HP, shows no signs of near-term recovery, posing substantial challenges for overall corporate health.

Financial metrics reveal deepening issues. According to InvestingPro data, the company’s gross margin sits at a modest 20.89%. Compounding these margin pressures, memory component expenses have surged dramatically, with DRAM and NAND prices escalating between 50% and 300% over the past six months.

  • Compressed Profitability: Gross margins remain thin at 20.89%
  • Spiraling Component Costs: Memory chip prices have jumped 50-300%
  • Reduced Margin Outlook: 2026 margin expectations cut by 70-90 basis points
  • Earnings Adjustment: EPS forecast lowered by 9% to $2.98

Contrasting Performance Metrics Emerge

Despite the pessimistic analyst stance, HP delivered unexpectedly strong third-quarter results. The company reported earnings per share of $0.75, exceeding the $0.74 consensus estimate, while revenue climbed to $13.93 billion. Its personal computer division recorded 6% growth, providing a silver lining amid broader concerns.

This performance prompted UBS to raise its price target from $26 to $29, though the firm maintained its “Neutral” rating on the stock. The conflicting analyst perspectives highlight the uncertainty surrounding HP’s trajectory.

Should investors sell immediately? Or is it worth buying HP?

All eyes now turn to November 25th, when HP will release its fourth-quarter results. Market participants anticipate earnings of $0.92 per share on revenue of $14.79 billion, representing modest growth of 5.23%. The question remains whether these figures can overcome current market skepticism.

Technical and Fundamental Indicators Paint Mixed Picture

From a technical standpoint, HP shares currently trade at $24.53, reflecting a 14.26% decline over the past month. The twelve-month performance shows even greater pressure, with the stock down 32.78% over this period. These levels bring the April low of $21.71 uncomfortably close for current shareholders.

Valuation metrics present a contradictory signal. HP trades at a price-to-earnings ratio of 7.91, significantly below the industry average of 13.61, suggesting potential undervaluation. However, institutional investors have been reducing their positions, and Zacks maintains its unflattering Rank #4 (“Sell”) rating on the equity.

The technology firm now confronts multiple headwinds: analyst downgrades, rising component expenses, and persistent weakness in its core printer operations. The upcoming quarterly report will prove crucial in determining whether strength in personal computers can sufficiently offset challenges elsewhere in the business.

Ad

HP Stock: Buy or Sell?! New HP Analysis from January 2 delivers the answer:

The latest HP figures speak for themselves: Urgent action needed for HP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 2.

HP: Buy or sell? Read more here...

Tags: HP
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Bionxt Solutions Stock
Analysis

BioNxt Solutions: Clinical Milestones Set to Define 2026 Trajectory

January 2, 2026
TSMC Stock
Analysis

TSMC Strengthens Market Dominance with Dual Technological and Geopolitical Wins

January 2, 2026
Johnson & Johnson Stock
Analysis

Institutional Investors Show Diverging Views on Johnson & Johnson Stock

January 2, 2026
Next Post
KKR Stock

KKR's Strategic Expansion and Record Performance Fuel Growth Momentum

Emerson Electric Stock

Emerson Electric Stock Plunges Despite Shareholder Incentives

Graphic Packaging Stock

Graphic Packaging Shares Plunge to New Low Amid Downgraded Outlook

Recommended

Finance_Budgeting (1)

Analyst Downgrades Brown Browns Outlook

2 years ago
Seaboard Stock

Seaboard Shares: Assessing the Foundation of a Rebound

2 weeks ago
Robert Half Stock

Robert Half Faces Market Headwinds Amid Sector Challenges

4 months ago
PayPal Stock

PayPal’s Strategic Push Meets Market Skepticism

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Institutional Investors Show Diverging Views on Johnson & Johnson Stock

The Tech-Heavy Engine Driving a Top Global ETF

Ethereum’s 2026 Mandate: Building Beyond Speculation

Electro Optic Systems Stock Soars on Tripled Order Backlog and New Governance Rules

Super Micro’s AI Server Launch Fails to Impress Investors

Assessing PayPal: A Value Opportunity or a Value Trap?

Trending

Bionxt Solutions Stock
Analysis

BioNxt Solutions: Clinical Milestones Set to Define 2026 Trajectory

by Andreas Sommer
January 2, 2026
0

Entering the new year, BioNxt Solutions (BNXT) carries significant momentum, with investor focus shifting from near-term volatility...

TSMC Stock

TSMC Strengthens Market Dominance with Dual Technological and Geopolitical Wins

January 2, 2026
CureVac Stock

CureVac Acquisition Enters Final Phase as BioNTech Integration Accelerates

January 2, 2026
Johnson & Johnson Stock

Institutional Investors Show Diverging Views on Johnson & Johnson Stock

January 2, 2026
MSCI World ETF Stock

The Tech-Heavy Engine Driving a Top Global ETF

January 2, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions: Clinical Milestones Set to Define 2026 Trajectory
  • TSMC Strengthens Market Dominance with Dual Technological and Geopolitical Wins
  • CureVac Acquisition Enters Final Phase as BioNTech Integration Accelerates

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com